On the potential of thioredoxin reductase inhibitors for cancer therapy

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Cellular processing of platinum anticancer drugs

Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801

GLUTATHIONE TRANSFERASES

Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group

Clark, L. (1996) · JAMA · doi:10.1001/jama.276.24.1957 · Cited by 2,719

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.

Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662

Physiological functions of thioredoxin and thioredoxin reductase

Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525

Fundamentals of Enzyme Kinetics

(1979) · Elsevier eBooks · doi:10.1016/c2013-0-04130-8 · Cited by 2,059

A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050

The role of glutathione in cancer

Balendiran, G. K., Dabur, R., & Fraser, D. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 927

Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance

Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741

Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase

Ganther, H. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1657 · Cited by 689

Flavins and Flavoproteins: Proceedings of the Eighth International Symposium, Brighton, England, July 9–13, 1984

(1984) · De Gruyter eBooks · doi:10.1515/9783111521350 · Cited by 681

The ATP-dependent glutathione S-conjugate export pump

Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 654

Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

Pommier, Y., Sordet, O., Antony, S., Hayward, R. L., & Kohn, K. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207515 · Cited by 560

Redox Control of Cell Death

Ueda, S., Masutani, H., Nakamura, H., Tanaka, T., Ueno, M., & Yodoi, J. (2002) · Antioxidants & Redox Signaling · doi:10.1089/15230860260196209 · Cited by 548

A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity.

Tamura, T., & Stadtman, T. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1006 · Cited by 539

Human Placenta Thioredoxin Reductase

Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H., & Becker, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20096 · Cited by 536

Structure and mechanism of mammalian thioredoxin reductase: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence

Zhong, L., Arnér, E. S. J., & Holmgren, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100114897 · Cited by 527

Thioredoxin Reductase Is Irreversibly Modified by Curcumin

Fang, J., Lu, J., & Holmgren, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414645200 · Cited by 521

Essential Role for Mitochondrial Thioredoxin Reductase in Hematopoiesis, Heart Development, and Heart Function

Conrad, M., Jakupoglu, C., Moreno, S. G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A. K., Just, U., Sinowatz, F., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9414-9423.2004 · Cited by 485

The thioredoxin system—From science to clinic

Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479

Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety

Kelley, S. K., Harris, L. A., Xie, D., DeForge, L., Totpal, K., Bussiere, J., & Fox, J. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 445

Thioredoxin-dependent Redox Regulation of p53-mediated p21 Activation

Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., & Nikaido, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35809 · Cited by 428

Essential Role of Selenium in the Catalytic Activities of Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant Enzymes with Selenocysteine Mutations

Zhong, L., & Holmgren, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000690200 · Cited by 427

Thioredoxin reductase as a pathophysiological factor and drug target

Becker, K., Gromer, S., Schirmer, R. H., & Müller, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01703.x · Cited by 388

Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.

Nagane, M., Pan, G., Weddle, J. J., Dixit, V. M., Cavenee, W. K., & Huang, H. (2000) · PubMed · Cited by 387

Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.

Russo, A., DeGraff, W., Friedman, N., & Mitchell, J. B. (1986) · PubMed · Cited by 384

Cytoplasmic Thioredoxin Reductase Is Essential for Embryogenesis but Dispensable for Cardiac Development

Jakupoglu, C., Przemeck, G. K. H., Schneider, M., Moreno, S. G., Mayr, N., Hatzopoulos, A. K., de Angelis, M. H., Wurst, W., Bornkamm, G. W., Brielmeier, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1980-1988.2005 · Cited by 363

Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme

Sandalova, T., Zhong, L., Lindqvist, Y., Holmgren, A., & Schneider, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171178698 · Cited by 343

Thioredoxin reductase: Two modes of catalysis have evolved

Williams, C. H., Arscott, L. D., Müller, S., Lennon, B. W., Ludwig, M. L., Wang, P., Veine, D. M., Becker, K., & Schirmer, R. H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01702.x · Cited by 343

The thioredoxin-thioredoxin reductase system: over-expression in human cancer.

Lincoln, D. T., Emadi, E. M. A., Tonissen, K. F., & Clarke, F. M. (2003) · PubMed · Cited by 337

Inhibition of Mammalian Thioredoxin Reductase by Some Flavonoids: Implications for Myricetin and Quercetin Anticancer Activity

Lu, J., Papp, L. V., Fang, J., Rodriguez-Nieto, S., Zhivotovsky, B., & Holmgren, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3310 · Cited by 326

Redox Regulation of Cell Signaling by Selenocysteine in Mammalian Thioredoxin Reductases

Sun, Q.-A., Wu, Y., Zappacosta, F., Jeang, K.-T., Lee, B. J., Hatfield, D. L., & Gladyshev, V. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24522 · Cited by 323

Gold(III) Dithiocarbamate Derivatives for the Treatment of Cancer: Solution Chemistry, DNA Binding, and Hemolytic Properties

Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., & Fregona, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509288 · Cited by 314

Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems

Sun, Q.-A., Kirnarsky, L., Sherman, S., & Gladyshev, V. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051454398 · Cited by 312

Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.

Berggren, M. I., Gallegos, A. C., Gasdaska, J. R., Gasdaska, P. Y., Warneke, J. A., & Powis, G. (1996) · PubMed · Cited by 306

Selenomethionine regulation of p53 by a ref1-dependent redox mechanism

Seo, Y. R., Kelley, M. R., & Smith, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212319799 · Cited by 280

Thioredoxin Reductase 1 Deficiency Reverses Tumor Phenotype and Tumorigenicity of Lung Carcinoma Cells

Yoo, M.-H., Xu, X.-M., Carlson, B. A., Gladyshev, V. N., & Hatfield, D. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600012200 · Cited by 270

Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity, and DNA Binding Properties

Marcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266

Rat and Calf Thioredoxin Reductase Are Homologous to Glutathione Reductase with a Carboxyl-terminal Elongation Containing a Conserved Catalytically Active Penultimate Selenocysteine Residue

Zhong, L., Arnér, E. S. J., Ljung, J., Åslund, F., & Holmgren, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8581 · Cited by 263

Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.

Gliniak, B., & Le, T. (1999) · PubMed · Cited by 261

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

Sullivan, A., Syed, N., Gasco, M., Bergamaschi, D., Trigiante, G., Attard, M., Hiller, L., Farrell, P. J., Smith, P., Lu, X., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207428 · Cited by 247

Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.

Baker, A. F., Payne, C. M., Briehl, M. M., & Powis, G. (1997) · PubMed · Cited by 240

Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.

Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., Okamoto, T., Yodoi, J., Kuwano, M., & Kohno, K. (1995) · PubMed · Cited by 237

The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli

Arscott, L. D., Gromer, S., Schirmer, R. H., Becker, K., & Williams, C. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3621 · Cited by 232

Thioredoxin reductase

Mustacich, D. J., & Powis, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460001 · Cited by 231

Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds

Witte, A.-B., Anestål, K., Jerremalm, E., Ehrsson, H., & Arnér, E. S. J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.025 · Cited by 225

Active sites of thioredoxin reductases: Why selenoproteins?

Gromer, S., Johansson, L., Bauer, H., Arscott, L. D., Rauch, S., Ballou, D. P., Williams, C. H., Schirmer, R. H., & Arnér, E. S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134510100 · Cited by 220

Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions

Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213

Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases

Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206

Mammalian Selenoprotein Thioredoxin-glutathione Reductase

Su, D., Novoselov, S. V., Sun, Q.-A., Moustafa, M. E., Zhou, Y., Oko, R., Hatfield, D. L., & Gladyshev, V. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503638200 · Cited by 204

Cloning and sequencing of a human thioredoxin reductase

Gasdaska, P. Y., Gasdaska, J. R., Cochran, S., & Powis, G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01003-w · Cited by 203

Mammalian Thioredoxin Reductase Is Irreversibly Inhibited by Dinitrohalobenzenes by Alkylation of Both the Redox Active Selenocysteine and Its Neighboring Cysteine Residue

Nordberg, J., Zhong, L., Holmgren, A., & Arnér, E. S. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10835 · Cited by 200

Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake

Jiang, C., Jiang, W., Ip, C. C. Y., Ganther, H. E., & Lü, J. (1999) · Molecular Carcinogenesis · Cited by 200

Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data

Cortés, A., Cascante, M., Cárdenas, M. L., & Cornish-Bowden, A. J. (2001) · Biochemical Journal · doi:10.1042/bj3570263 · Cited by 197

Regulation of the Mammalian Selenoprotein Thioredoxin Reductase 1 in Relation to Cellular Phenotype, Growth, and Signaling Events

Rundlöf, A.-K., & Arnér, E. S. J. (2004) · Antioxidants & Redox Signaling · doi:10.1089/152308604771978336 · Cited by 195

New Principles in Medicinal Organometallic Chemistry

Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194

A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells

Friesen, C., Kiess, Y., & Debatin, K.-M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401431 · Cited by 194

1-Chloro-2,4-dinitrobenzene Is an Irreversible Inhibitor of Human Thioredoxin Reductase

Arnér, E. S. J., Björnstedt, M., & Holmgren, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3479 · Cited by 187

Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

Soini, Y., Kahlos, K., Näpänkangas, U., Kaarteenaho–Wiik, R., Säily, M., Koistinen, P., Pääakkö, P., Holmgren, A., & Kinnula, V. L. (2001) · PubMed · Cited by 187

Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer

Troester, M. A., Hoadley, K. A., Sørlie, T., Herbert, B.-S., Børresen-Dale, A.-L., Lønning, P. E., Shay, J. W., Kaufmann, W. K., & Perou, C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0107 · Cited by 179

Human mitochondrial thioredoxin reductase: cDNA cloning, expression and genomic organization

Miranda‐Vizuete, A., Damdimopoulos, A. E., Pedrajas, J. R., Gustafsson, J., & Spyrou, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00286.x · Cited by 178

Induction of mitochondrial permeability transition by auranofin, a Gold(I)‐phosphine derivative

Rigobello, M. P., Scutari, G., Boscolo, R., & Bindoli, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704823 · Cited by 178

Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex

Arnér, E. S. J., Nakamura, H., Sasada, T., Yodoi, J., Holmgren, A., & Spyrou, G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00698-0 · Cited by 178

Synthesis, Characterization, and Comparative in Vitro Cytotoxicity Studies of Platinum(II), Palladium(II), and Gold(III) Methylsarcosinedithiocarbamate Complexes

Giovagnini, L., Ronconi, L., Aldinucci, D., Lorenzon, D., Sitran, S., & Fregona, D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049191x · Cited by 175

Motexafin Gadolinium, a Tumor-selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase

Hashemy, S. I., Ungerstedt, J. S., Avval, F. Z., & Holmgren, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511373200 · Cited by 162

The Mitochondrial Thioredoxin System

Miranda‐Vizuete, A., Damdimopoulos, A. E., & Spyrou, G. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.4-801 · Cited by 158

Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats.

Rozell, B., Ha, H., Luthman, M., & Holmgren, A. (1985) · PubMed · Cited by 156

Human Thioredoxin Reductase Is Efficiently Inhibited by (2,2‘:6‘,2‘ ‘-Terpyridine)platinum(II) Complexes. Possible Implications for a Novel Antitumor Strategy

Becker, K., Herold‐Mende, C. C., Park, J. J., Lowe, G. M., & Schirmer, R. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001014i · Cited by 150

Lead-In Phase to Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation for Patients With Brain Metastases: Centralized Assessment of Magnetic Resonance Imaging, Neurocognitive, and Neurologic End Points

Mehta, M. P., Shapiro, W. R., Glantz, M., Patchell, R. A., Weitzner, M. A., Meyers, C. A., Schultz, C. J., Roa, W., Leibenhaut, M. H., Ford, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.500 · Cited by 148

Flavins and flavoproteins

TEALE, F. W. J. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90259-6 · Cited by 144

Cyclodextrin-Derived Diorganyl Tellurides as Glutathione Peroxidase Mimics and Inhibitors of Thioredoxin Reductase and Cancer Cell Growth

McNaughton, M., Engman, L., Birmingham, A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030916r · Cited by 143

Interactions of Quinones with Thioredoxin Reductase

Čėnas, N., Nivinskas, H., Anusevičius, Ž., Šarlauskas, J., Lederer, F., & Arnér, E. S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310292200 · Cited by 141

Purification of Mitochondrial Thioredoxin Reductase and Its Involvement in the Redox Regulation of Membrane Permeability

Rigobello, M. P., Callegaro, M. T., Barzon, E., Benetti, M., & Bindoli, A. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00216-5 · Cited by 138

Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)

Omata, Y., Folan, M., Shaw, M., Messer, R. L. W., Lockwood, P. E., Hobbs, D. T., Bouillaguet, S., Sano, H., Lewis, J. B., & Wataha, J. C. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.01.012 · Cited by 129

Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma

Kahlos, K., Soini, Y., S�ily, M., Koistinen, P., Kakko, S., P��kk�, P., Holmgren, A., & Kinnula, V. L. (2001) · International Journal of Cancer · Cited by 127

Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II)

Sasada, T., Nakamura, H., Ueda, S., Sato, N., Kitaoka, Y., Gon, Y., Takabayashi, A., Spyrou, G., Holmgren, A., & Yodoi, J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00101-x · Cited by 126

Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.

Gallegos, A. C., Berggren, M. I., Gasdaska, J. R., & Powis, G. (1997) · PubMed · Cited by 123

Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity

Seemann, S., & Hainaut, P. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208549 · Cited by 123

Contrasting Patterns of Regulation of the Antioxidant Selenoproteins, Thioredoxin Reductase, and Glutathione Peroxidase, in Cancer Cells

Gladyshev, V. N., Factor, V. M., Housseau, F., & Hatfield, D. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9495 · Cited by 121

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase

Schallreuter, K. U., Gleason, F. K., & Wood, J. M. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90199-n · Cited by 121

Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism

Biterova, E. I., Turanov, A. A., Gladyshev, V. N., & Barycki, J. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504218102 · Cited by 120

Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells

Čėnas, N., Prast‐Nielsen, S., Nivinskas, H., Šarlauskas, J., & Arnér, E. S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511972200 · Cited by 119

Curcumin impairs tumor suppressor p53 function in colon cancer cells

Moos, P. J., Edes, K., Mullally, J. E., & Fitzpatrick, F. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh163 · Cited by 119

Thioredoxin Reductase as a Potential Molecular Target for Anticancer Agents That Induce Oxidative Stress

Smart, D. D., Ortiz, K. L., Mattson, D., Bradbury, C. M., Bisht, K. S., Sieck, L., Brechbiel, M. W., & Gius, D. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3990 · Cited by 117

Targeting Apoptotic Pathways in Cancer Cells

Denicourt, C., & Dowdy, S. F. (2004) · Science · doi:10.1126/science.1102974 · Cited by 114

Cloning, sequencing and functional expression of a novel human thioredoxin reductase

Gasdaska, P. Y., Berggren, M. M., Berry, M. J., & Powis, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01638-x · Cited by 112

Effect of Auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase

Rigobello, M. P., Folda, A., Baldoin, M. C., Scutari, G., & Bindoli, A. (2005) · Free Radical Research · doi:10.1080/10715760500135391 · Cited by 107

Novel Concepts in the Development of Platinum Antitumor Drugs

Fuertes, M. A., Castilla, J., Alonso, C., & Perez, J. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023353958 · Cited by 105

Current Chemotherapy for Glioblastoma

Parney, I. F., & Chang, S. M. (2003) · The Cancer Journal · doi:10.1097/00130404-200305000-00003 · Cited by 104

Loss of selenium from selenoproteins: Conversion of selenocysteine to dehydroalanine in vitro

Ma, S., Caprioli, R. M., Hill, K. E., & Burk, R. F. (2003) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(03)00141-7 · Cited by 104

A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase

Gromer, S., Wissing, J. B., BEHNE, D., Ashman, K., Schirmer, R. H., Floh�, L., & Becker, K. (1998) · Biochemical Journal · doi:10.1042/bj3320591 · Cited by 103

Cisplatin Damage: Are DNA Repair Proteins Saviors or Traitors to the Cell?

Zorbas, H., & Keppler, B. K. (2005) · ChemBioChem · doi:10.1002/cbic.200400427 · Cited by 103

Heterogeneity within Animal Thioredoxin Reductases

Sun, Q.-A., Zappacosta, F., Factor, V. M., Wirth, P. J., Hatfield, D. L., & Gladyshev, V. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004750200 · Cited by 101

Novel platinum(IV) complexes induce rapid tumor cell death in vitro

Kaluđerović, G. N., Miljković, D. M., Momčilović, M. B., Djinović, V. M., Stojković, M. M., Sabo, T. J., & Trajković, V. (2005) · International Journal of Cancer · doi:10.1002/ijc.21080 · Cited by 100

Evidence for intriguingly complex transcription of human thioredoxin reductase 1

Rundlöf, A.-K., Janard, M., Miranda‐Vizuete, A., & Arnér, E. S. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.004 · Cited by 99

The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours

Hall, M. D., Alderden, R. A., Zhang, M., Beale, P. J., Cai, Z., Lai, B. C. H., Stampfl, A. P. J., & Hambley, T. W. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.01.011 · Cited by 98

The Mammalian Testis-Specific Thioredoxin System

Miranda‐Vizuete, A., Sadek, C. M., Jiménez, A., Krause, W. J., Šutovský, P., & Oko, R. J. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978327 · Cited by 97

Mechanistic Studies on a Novel, Highly Potent Gold-Phosphole Inhibitor of Human Glutathione Reductase

Deponte, M., Urig, S., Arscott, L. D., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C. C., Končarević, S., Meyer, M., Davioud–Charvet, E., Ballou, D. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412519200 · Cited by 93

Reaction Mechanism and Regulation of Mammalian Thioredoxin/Glutathione Reductase

Sun, Q.-A., Su, D., Novoselov, S. V., Carlson, B. A., Hatfield, D. L., & Gladyshev, V. N. (2005) · Biochemistry · doi:10.1021/bi051321w · Cited by 87

A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines

Shi, C.-J., Yu, L.-Z., Yang, F., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.032 · Cited by 86

Antiangiogenic Activity of Selenium in Cancer Chemoprevention: Metabolite-Specific Effects

Lü, J., & Jiang, C. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc401_12 · Cited by 78

A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines

Zhao, F., Yan, J., Deng, S.-J., Lan, L., He, F., Kuang, B., & Zeng, H. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.010 · Cited by 73

Expression of Antioxidant Enzymes in Astrocytic Brain Tumors

Haapasalo, H. K., Kyläniemi, M., Paunu, N., Kinnula, V. L., & Soini, Y. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00015.x · Cited by 69

Natural product based inhibitors of the thioredoxin–thioredoxin reductase system

Wipf, P., Lynch, S. M., Birmingham, A., Tamayo‐Castillo, G., Jiménez, A., Campos, N., & Powis, G. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b402431a · Cited by 68

Overexpression of Enzymatically Active Human Cytosolic and Mitochondrial Thioredoxin Reductase in HEK-293 Cells

Nalvarte, I., Damdimopoulos, A. E., Nystöm, C., Nordman, T., Miranda‐Vizuete, A., Olsson, J. M., Eriksson, L. C., Björnstedt, M., Arnér, E. S. J., & Spyrou, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408494200 · Cited by 66

The Functional Role of Selenocysteine (Sec) in the Catalysis Mechanism of Large Thioredoxin Reductases: Proposition of a Swapping Catalytic Triad Including a Sec‐His‐Glu State

Brandt, W., & Wessjohann, L. A. (2005) · ChemBioChem · doi:10.1002/cbic.200400276 · Cited by 66

Identification of differentially expressed genes associated with androgen‐independent growth of prostate cancer

Mohler, J. L., Morris, T. L., Ford, O. H., Alvey, R. F., Sakamoto, C., & Gregory, C. W. (2002) · The Prostate · doi:10.1002/pros.10086 · Cited by 63

The 58 kDa mouse selenoprotein is a BCNU‐sensitive thioredoxin reductase

Gromer, S., Schirmer, R. H., & Becker, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00816-8 · Cited by 62

Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants

Engman, L., Al-Maharik, N., McNaughton, M., Birmingham, A., & Powis, G. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200302000-00009 · Cited by 62

Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system

Jönsson‐Videsäter, K., Björkhem‐Bergman, L., Hossain, A., Söderberg, A., Eriksson, L. C., Paul, C., Rosén, A., & Björnstedt, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.021 · Cited by 60

Induction of Apoptosis by Chemotherapeutic Drugs without Generation of Reactive Oxygen Species

Sentürker, S., Tschirret-Guth, R. A., Morrow, J. D., Levine, R. L., & Shacter, E. B. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2681 · Cited by 59

Potential for selective modulation of glutathione in cancer chemotherapy

Chen, X., Carystinos, G. D., & Batist, G. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00166-x · Cited by 58

Alternative Splicing Involving the Thioredoxin Reductase Module in Mammals: A Glutaredoxin-Containing Thioredoxin Reductase 1

Su, D., & Gladyshev, V. N. (2004) · Biochemistry · doi:10.1021/bi048478t · Cited by 58

Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study

Mukherjee, A., Westwell, A. D., Bradshaw, T. D., Stevens, M. F. G., Carmichael, J., & Martin, S. G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602338 · Cited by 56

Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells

Engman, L., Al‐Maharik, N., McNaughton, M., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.08.021 · Cited by 53

Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination – An effective strategy to improve clinical treatment

Lu, D.-Y., Chen, X. L., & Ding, J. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.07.023 · Cited by 52

Platinum(IV) Anticancer Complexes

Hall, M. D., Dolman, R. C., & Hambley, T. W. (2004) · CRC Press eBooks · doi:10.1201/b12414-9 · Cited by 52

The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes

Mellor, H. R., Snelling, S. J. B., Hall, M. D., Modok, S., Jaffar, M., Hambley, T. W., & Callaghan, R. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.016 · Cited by 51

Thioredoxin Reductase Regulates Angiogenesis by Increasing Endothelial Cell-Derived Vascular Endothelial Growth Factor

Streicher, K. L., Sylte, M. J., Johnson, S., & Sordillo, L. M. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5002_13 · Cited by 51

Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells

Gan, L., Yang, X., Liu, Q., & Xu, H. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20585 · Cited by 49

Synthesis of 5-Nitro-2-furancarbohydrazides and Their cis-Diamminedichloroplatinum Complexes as Bitopic and Irreversible Human Thioredoxin Reductase Inhibitors

Millet, R., Urig, S., Jacob, J., Amtmann, E., Moulinoux, J.-P., Gromer, S., Becker, K., & Davioud–Charvet, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050256l · Cited by 45

Novel chemotherapeutic agents for the treatment of glioblastoma multiforme

Jendrossek, V., Belka, C., & Bamberg, M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.12.1899 · Cited by 43

Antiglioma activity of 2,2′:6′,2ʺ-terpyridineplatinum(II) complexes in a rat model—Effects on cellular redox metabolism

Ahmadi, R., Urig, S., Hartmann, M., Helmke, B. M., Končarević, S., Allenberger, B., Kienhoefer, C., Neher, M., Steiner, H. H., Unterberg, A. W., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.031 · Cited by 42

Human Thioredoxin Reductase Gene Localization to Chromosomal Position 12q23–q24.1 and mRNA Distribution in Human Tissue

Gasdaska, J. R., Gasdaska, P. Y., Gallegos, A. C., & Powis, G. (1996) · Genomics · doi:10.1006/geno.1996.0554 · Cited by 42

The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria

Rigobello, M. P., Folda, A., Scutari, G., & Bindoli, A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.07.007 · Cited by 41

The role of the p53 and Rb-1 genes in cancer, development and apoptosis

Hooper, M. (1994) · Journal of Cell Science · doi:10.1242/jcs.1994.supplement_18.3 · Cited by 41

Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma

Turunen, N., Karihtala, P., Mäntyniemi, A., Sormunen, R. T., Holmgren, A., Kinnula, V. L., & Soini, Y. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120207.x · Cited by 38

Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds

Pallis, M., Bradshaw, T. D., Westwell, A. D., Grundy, M. A., Stevens, M. F. G., & Russell, N. H. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00471-4 · Cited by 32

Superoxide production by dinitrophenyl‐ derivatized thioredoxin reductase ‐ a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes

Arnér, E. S. J. (1999) · BioFactors · doi:10.1002/biof.5520100220 · Cited by 29

Malignant gliomas

Wen, P. Y., & Kesari, S. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0042-4 · Cited by 27

Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase

Rigobello, M. P., Vianello, F., Folda, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.050 · Cited by 26

Individualised cancer therapeutics: dream or reality?

Senzer, N. N., Shen, Y., Hill, C., & Nemunaitis, J. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1189 · Cited by 10

Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling

Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677

Selenium and Selenoproteins: It’s Role in Regulation of Inflammation

Hariharan, S., & Dharmaraj, S. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00690-x · Cited by 659

N-Heterocyclic carbene metal complexes in medicinal chemistry

Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526

Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications

Lei, X. G., Zhu, J.-H., Cheng, W.-H., Bao, Y., Ho, Y.-S., Reddi, A. R., Holmgren, A., & Arnér, E. S. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00010.2014 · Cited by 429